Trial Profile

EVALUATION OF CEREBRAL THROMBOEMBOLISM AFTER TAVR

Status: Completed

Phase of Trial: Phase III

Latest Information Update: 29 Oct 2020

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Rivaroxaban (Primary) ; Clopidogrel; Salicylic acid
Indications Embolism
Focus Therapeutic Use
Acronyms EARTH TAVR

Most Recent Events

01 Sep 2020 Results (n=36) presented at the ESC Congress 2020 - Annual Congress of the European Society of Cardiology.
27 Sep 2018 Status changed from recruiting to completed.
20 Oct 2016 New trial record

You need to be a logged in or subscribed to view this content Request demo (opens in a new window)

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com